@divy28jan.bsky.social
Init post .. init contribution to the lab :)
Just before the holidays, here is the latest from the Oricchio lab. In collaboration with the hemato-oncology team, we established a new model to test therapies on lymphoma patient samples by preserving the tissue composition and architecture of the original tumors. www.nature.com/articles/s41...
Development of patient-derived lymphomoids with preserved tumor architecture for lymphoma therapy screening - Nature Communications
Choosing the most effective anti-cancer therapy is difficult due to the high degree of tumour cell and tumour microenvironment heterogeneity. Here, the authors develop a platform for the generation of...
www.nature.com
December 18, 2024 at 5:18 PM
Init post .. init contribution to the lab :)